Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients
Pere Domingo, Maria Karuna Lamarca, José M. Gallego-Escuredo, Ferran Torres, Joan C. Domingo, Joan Villarroya, Ma Del Mar Gutierrez, Ma Gracia Mateo, Francesc Vidal, Francesc Villarroya, Marta Giralt
Navegar pels temes de recerca de 'Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients'. Junts formen un fingerprint únic.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science